English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Genome-wide CRISPR/Cas9 screening identifies proteasome-related specific vulnerabilities as potential treatment options of proteasome inhibitor-resistant multiple myeloma

MPS-Authors
/persons/resource/persons241489

Stolze,  S.
Mass Spectrometry, MPI for Plant Breeding Research, Max Planck Society;

/persons/resource/persons214459

Nakagami,  H.
Mass Spectrometry, MPI for Plant Breeding Research, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Andrej, B., Lenka, B., Buchler, L., Stolze, S., Sobh, A., Kraus, M., et al. (2021). Genome-wide CRISPR/Cas9 screening identifies proteasome-related specific vulnerabilities as potential treatment options of proteasome inhibitor-resistant multiple myeloma. Clinical Lymphoma Myeloma and Leukemia, 21, S88-S89.


Cite as: https://hdl.handle.net/21.11116/0000-000A-3033-6
Abstract
There is no abstract available